Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Gastric Cancer × vorolanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1 Renal Cell Cancer Metastatic 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Tumors 1 Advanced Gastric Cancer 1

Interventions

Paclitaxel 5 apatinib 4 camrelizumab 3 S 1 (combination) 2 Capecitabine 2 130-nm albumin-bound paclitaxel 2 vorolanib 1 titanium silicide 1 spartalizumab 1 raltitrexed 1 lobaplatin 1 Ramucirumab 1 Oxaliplatin 1 Gastrectomy 1 Docetaxel 1 Control Groups 1 Cisplatin 1 CF regimen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03286244 2019-02-21

Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

AnewPharma

Phase 1 Unknown

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡